Foundation for Innovative New Diagn
$40,000,000.00 CAD
- Department
- Global Affairs Canada
- Program
- —
- Recipient country
- Switzerland
- Fiscal year
- 2020-2021
- Agreement period
- March 31, 2021 – August 31, 2023
- Reference
- dfatd-maecd:064-2024-2025-Q2-00442
Published purpose
This project builds on Canada’s funding to the Foundation for Innovative New Diagnostics (FIND) during COVID-19. The initial project aims at accelerate the roll-out of safe, affordable, and effective COVID-19 diagnostics in Low- and Lower-Middle Income Countries. This project supports FIND in using testing technologies developed during COVID-19 to expand the range of diseases detected with a single test. This includes other respiratory diseases, sexually transmitted infections, and Human papillomavirus (HPV)-based screening for cervical cancer. The project aims to increase testing for the most marginalized, including women, children, and vulnerable groups. Project activities include: (1) supporting the development of more straightforward sample collection methods, including self-sampling; and (2) conducting in-country customer preference surveys and barrier-to-access surveys to guide the final development and introduction of tests.
In plain English AI-generated
This project funds the Foundation for Innovative New Diagnostics to expand COVID-19 testing technologies to detect additional diseases, including respiratory infections, STIs, and HPV-related cervical cancer, with a focus on increasing access for marginalized groups in low- and lower-middle-income countries.
Category: Health Primarily funds activity outside Canada
Based on the published description. See how AI categorization works — the linked official record is authoritative.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.